Nordlund J, Syvänen AC. Epigenetics in pediatric acute lymphoblastic leukemia. Semin Cancer Biol. 2018;51:129–38.

Liu YF, Wang BY, Zhang WN, Huang JY, Li BS, Zhang M, et al. Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia. EBioMedicine. 2016;8:173–83.

Article  PubMed  PubMed Central  Google Scholar 

Zhang X, Lu XA, Yang J, Zhang G, Li J, Song L, et al. Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features. Blood Adv. 2020;4:2325–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Davila ML, Riviere I, Wang X, Bartido S, Park J, Curran K, et al. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci Transl Med. 2014;6:224ra25.

Article  PubMed  PubMed Central  Google Scholar 

Wynne J, Wright D, Stock W. Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemia. Blood Adv. 2019;3:96–104.

Article  CAS  PubMed  PubMed Central  Google Scholar 

O’Brien MM, Ji L, Shah NN, Rheingold SR, Bhojwani D, Joanna SY, et al. A phase 2 trial of inotuzumab ozogamicin (InO) in children and young adults with relapsed or refractory (R/R) CD22+ B-acute lymphoblastic leukemia (B-ALL): results from Children’s Oncology Group Protocol AALL1621. Blood. 2019;134:741.

Article  Google Scholar 

Chu SH, Song EJ, Chabon J, Minehart J, Feng Z, Ross K, et al. Targeting the DNA damage response pathway in MLL-rearranged B-acute lymphoblastic leukemias. Blood. 2017;130:3880.

Google Scholar 

Groelly FJ, Fawkes M, Dagg RA, Blackford AN, Tarsounas M. Targeting DNA damage response pathways in cancer. Nat Rev Cancer. 2023;23:78–94.

Article  CAS  PubMed  Google Scholar 

Lu H, Yang M, Zhou Q. Reprogramming transcription after DNA damage: recognition, response, repair, and restart. Trends Cell Biol. 2023;33:682–94.

Article  CAS  PubMed  Google Scholar 

Pezone A, Olivieri F, Napoli MV, Procopio A, Avvedimento EV, Gabrielli A. Inflammation and DNA damage: cause, effect or both. Nat Rev Rheumatol. 2023;19:200–11.

Article  CAS  PubMed  Google Scholar 

Caldecott KW, Ward ME, Nussenzweig A. The threat of programmed DNA damage to neuronal genome integrity and plasticity. Nat Genet. 2022;54:115–20.

Article  CAS  PubMed  Google Scholar 

Zhuang S, Yang Z, Cui Z, Zhang Y, Che F. Epigenetic alterations and advancement of lymphoma treatment. Ann Hematol. 2024;103:1435–54.

Article  PubMed  Google Scholar 

Li X, Ma S, Deng Y, Yi P, Yu J. Targeting the RNA m6A modification for cancer immunotherapy. Mol Cancer. 2022;21:76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu R, Jiang D, Wang Y, Wang X. N6-methyladenosine (m6A) methylation in mRNA with a dynamic and reversible epigenetic modification. Mol Biotechnol. 2016;58:450–9.

Article  CAS  PubMed  Google Scholar 

Widagdo J, Anggono V, Wong JJL. The multifaceted effects of YTHDC1-mediated nuclear m6A recognition. Trends Genet. 2022;38:325–32.

Article  CAS  PubMed  Google Scholar 

Xu C, Wang X, Liu K, Roundtree IA, Tempel W, Li Y, et al. Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain. Nat Chem Biol. 2014;10:927–9.

Article  CAS  PubMed  Google Scholar 

Xiao W, Adhikari S, Dahal U, Chen YS, Hao YJ, Sun BF, et al. Nuclear m6A reader YTHDC1 regulates mRNA splicing. Mol Cell. 2016;61:507–19.

Article  CAS  PubMed  Google Scholar 

Qiao Y, Sun Q, Chen X, He L, Wang D, Su R, et al. Nuclear m6A reader YTHDC1 promotes muscle stem cell activation/proliferation by regulating mRNA splicing and nuclear export. Elife. 2023;12:e82703.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu J, Gao M, He J, Wu K, Lin S, Jin L, et al. The RNA m6A reader YTHDC1 silences retrotransposons and guards ES cell identity. Nature. 2021;591:322–6.

Article  CAS  PubMed  Google Scholar 

Roundtree IA, Luo GZ, Zhang Z, Wang X, Zhou T, Cui Y, et al. YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs. Elife. 2017;6:e31311.

Article  PubMed  PubMed Central  Google Scholar 

Sheng Y, Wei J, Yu F, Xu H, Yu C, Wu Q, et al. A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex–mediated DNA replication. Blood. 2021;138:2838–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aguilar-Garrido P, Otero-Sobrino A, Navarro-Aguadero MÁ, Velasco-Estevez M, Gallardo M. The role of RNA-binding proteins in hematological malignancies. Int J Mol Sci. 2022;23:9552.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saluja S, Singh J, Jain A, Chaudhary S, Pethusamy K, Chattopadhyay P, et al. Delineating the role of interplay between m6A machinery genes and IGF2BP group of RNA-binding proteins in B-cell acute lymphoblastic leukemia (B-ALL). Blood. 2021;138:4472.

Article  Google Scholar 

Qin X, Su R, Yang L, Chan AK, Deng X, Qing Y, et al. Identification of ZNF217 as an essential oncogenic gene in B-cell acute lymphoblastic leukemia by CRISPR/Cas9-based library screening. Blood. 2019;134:1465.

Article  Google Scholar 

Li Y, Xia L, Tan K, Ye X, Zuo Z, Li M, et al. N6-Methyladenosine co-transcriptionally directs the demethylation of histone H3K9me2. Nat Genet. 2020;52:870–7.

Article  CAS  PubMed  Google Scholar 

Zhang C, Chen L, Peng D, Jiang A, He Y, Zeng Y, et al. METTL3 and N6-methyladenosine promote homologous recombination-mediated repair of DSBs by modulating DNA-RNA hybrid accumulation. Mol Cell. 2020;79:425–42.

Article  CAS  PubMed  Google Scholar 

Li X, Zhang Y, He F, Gao D, Che B, Cao X, et al. miR-582 suppresses the proliferation of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) cells and protects them from natural killer cell-mediated cytotoxicity. Front Immunol. 2022;13:853094.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Branzei D, Foiani M. Regulation of DNA repair throughout the cell cycle. Nat Rev Mol Cell Biol. 2008;9:297–308.

Article  CAS  PubMed  Google Scholar 

Mah L, El-Osta A, Karagiannis T. γH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia. 2010;24:679–86.

Article  CAS  PubMed  Google Scholar 

Tang C, Li MH, Chen YL, Sun HY, Liu SL, Zheng WW, et al. Chemotherapy-induced niche perturbs hematopoietic reconstitution in B-cell acute lymphoblastic leukemia. J Exp Clin Cancer Res. 2018;37:204.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oshima K, Zhao J, Pérez-Durán P, Brown JA, Patiño-Galindo JA, Chu T, et al. Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia. Nat Cancer. 2020;1:1113–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rampias T, Karagiannis D, Avgeris M, Polyzos A, Kokkalis A, Kanaki Z, et al. The lysine‐specific methyltransferase KMT 2C/MLL 3 regulates DNA repair components in cancer. EMBO Rep. 2019;20:e46821.

Article  PubMed  PubMed Central